Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Anaheim Clinical Trials, LLC, Anaheim, California Miami Dermatology and Laser Research, Miami, Florida Paddington Testing Company, Philadelphia, Pennsylvania